No photo of R. Ruijter

R. Ruijter

20022018
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2018

Open Access
22 Downloads (Pure)

Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours

Kaye, S., Aamdal, S., Jones, R., Freyer, G., Pujade-Lauraine, E., de Vries, E. G. E., Barriuso, J., Sandhu, S., Tan, D. S. W., Hartog, V., Kuenen, B., Ruijter, R., Kristensen, G. B., Nyakas, M., Barrett, S., Burke, W., Pietersma, D., Stuart, M., Emeribe, U. & Boven, E., 2012, In : British Journal of Cancer. 106, 11, p. 1728-1734

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File
22 Downloads (Pure)

Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies

Schoffski, P., Dumez, H., Ruijter, R., Miguel-Lillo, B., Soto-Matos, A., Alfaro, V. & Giaccone, G., 2011, In : Cancer Chemotherapy and Pharmacology. 68, 6, p. 1397-1403

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File

A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG(1) Monoclonal Antibody Directed Against EGFR in Patients with Advanced Solid Malignancies

Kuenen, B. C., Witteveen, P. O., Ruijter, R., Giaccone, G., Dontabhaktuni, A., Fox, F., Katz, T., Youssoufian, H., Zhu, J. M., Rowinsky, E. K. & Voest, E. E., 2010, In : Clinical Cancer Research. 16, 6, p. 1915-1923

Research output: Contribution to journalArticleAcademicpeer-review